Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility

Date:

NASDAQ | TSX: ACB
Canada’s Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients
EDMONTON, AB, Nov. 26, 2024 /PRNewswire/ – Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces developments in cannabis science from Aurora’s world class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these latest innovations demonstrate Aurora’s commitment to providing patients with ongoing access to superior product offerings on AuroraMedical.com.

“A

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...